Orion Corporation Release: The Androgen Receptor Inhibitor ODM-201 - New Insights In The Treatment Of Prostate Cancer

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ESPOO, Finland, Feb. 3, 2014 (GLOBE NEWSWIRE) -- Three posters on ODM-201 from two clinical trials (ARADES and ARAFOR), reviewing pharmacokinetic, safety and efficacy data were presented at the ASCO Genitourinary Cancers Symposium (Jan 30-2 Feb 2014) in San Francisco.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC